Почетна › Немалоклетни карцином плућа › Тенеси › Knoxville
Kliničke studije za Немалоклетни карцином плућа u gradu Knoxville, TN
15 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Knoxville i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Тражи се учесникФаза 3
- University of Tennessee - Knoxville, Knoxville
- University Cancer Specialists - Alcoa, Alcoa · 12 ми удаљено
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Тражи се учесникФаза 3
- University of Tennessee Medical Center Knoxville ( Site 0082), Knoxville
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Тражи се учесникФаза 3
- Thompson Cancer Survival Center ( Site 0168), Knoxville
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Тражи се учесникФаза 3
- The University of Tennessee Medical Center ( Site 3223), Knoxville
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Тражи се учесникФаза 1/2
- University of Tennessee Health Science Center, Knoxville
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 3
- Tennessee Cancer Specialists, Knoxville
- Tennessee Cancer Specialists - Parkwest Location, Knoxville
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Тражи се учесникФаза 3
- University of Tennessee Medical Center, Knoxville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- University of Tennessee Medical Center, Knoxville
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Тражи се учесникФаза 2/3
- University of Tennessee Medical Center, Knoxville
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 2
- University of Tennessee Medical Center, Knoxville
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Тражи се учесникФаза 2
- University of Tennessee Medical Center, Knoxville
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Тражи се учесникФаза 3
- Tennessee Cancer Specialists Dowell Springs location, Knoxville
- University of Tennessee Medical Center, Knoxville
- Tennessee Cancer Specialists - Parkwest Location, Knoxville
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Тражи се учесникФаза 2/3
- Tennessee Cancer Specialists - Knoxville - Old Weisgarber Road /ID# 277891, Knoxville
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- University of Tennessee Medical Center, Knoxville
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Тражи се учесникФаза 2
- University of Tennessee Medical Center, Knoxville
Studije za Немалоклетни карцином плућа u drugim gradovima
- Houston, TX143 студија
- New York City, NY123 студија
- Arlington, VA111 студија
- Nashville, TN97 студија
- Los Angeles, CA92 студија
- Boston, MA87 студија
- St. Louis, MO68 студија
- Baltimore, MD60 студија
- San Antonio, TX60 студија
- Chicago, IL59 студија
- Columbus, OH57 студија
- Seattle, WA55 студија
Ostale studije u gradu Knoxville
- Рак плућа12 студија
- Гојазност10 студија
- Рак дојке9 студија
- Рак (све врсте)8 студија
- Затајење срца7 студија
- Гојазност7 студија
- Метастатски карцином7 студија
- Меланом6 студија
- Плоскоклеточни карцином главе и врата6 студија
- ХОБП5 студија
- Висок крвни притисак5 студија
- Dijabetes tipa 25 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.